255 related articles for article (PubMed ID: 18958632)
21. The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells.
Shehu A; Albarracin C; Devi YS; Luther K; Halperin J; Le J; Mao J; Duan RW; Frasor J; Gibori G
Mol Endocrinol; 2011 May; 25(5):754-66. PubMed ID: 21372145
[TBL] [Abstract][Full Text] [Related]
22. Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer.
Nakamura H; Takada K; Arihara Y; Hayasaka N; Murase K; Iyama S; Kobune M; Miyanishi K; Kato J
Cancer Gene Ther; 2019 Sep; 26(9-10):313-322. PubMed ID: 30401882
[TBL] [Abstract][Full Text] [Related]
23. STEAP1 is overexpressed in cancers: a promising therapeutic target.
Moreaux J; Kassambara A; Hose D; Klein B
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):148-55. PubMed ID: 23142226
[TBL] [Abstract][Full Text] [Related]
24. Baicalein has protective effects on the 17β-estradiol-induced transformation of breast epithelial cells.
Chen Y; Wang J; Hong DY; Chen L; Zhang YY; Xu YN; Pan D; Fu LY; Tao L; Luo H; Shen XC
Oncotarget; 2017 Feb; 8(6):10470-10484. PubMed ID: 28060756
[TBL] [Abstract][Full Text] [Related]
25. 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.
Rachner TD; Schoppet M; Niebergall U; Hofbauer LC
Biochem Biophys Res Commun; 2008 Apr; 368(3):736-41. PubMed ID: 18252198
[TBL] [Abstract][Full Text] [Related]
26. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.
Grunewald TG; Diebold I; Esposito I; Plehm S; Hauer K; Thiel U; da Silva-Buttkus P; Neff F; Unland R; Müller-Tidow C; Zobywalski C; Lohrig K; Lewandrowski U; Sickmann A; Prazeres da Costa O; Görlach A; Cossarizza A; Butt E; Richter GH; Burdach S
Mol Cancer Res; 2012 Jan; 10(1):52-65. PubMed ID: 22080479
[TBL] [Abstract][Full Text] [Related]
27. KISS1 is down-regulated by 17beta-estradiol in MDA-MB-231 cells through a nonclassical mechanism and loss of ribonucleic acid polymerase II binding at the proximal promoter.
Huijbregts L; de Roux N
Endocrinology; 2010 Aug; 151(8):3764-72. PubMed ID: 20534720
[TBL] [Abstract][Full Text] [Related]
28. Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET.
Doran MG; Watson PA; Cheal SM; Spratt DE; Wongvipat J; Steckler JM; Carrasquillo JA; Evans MJ; Lewis JS
J Nucl Med; 2014 Dec; 55(12):2045-9. PubMed ID: 25453051
[TBL] [Abstract][Full Text] [Related]
29. Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells.
Park E; Gong EY; Romanelli MG; Lee K
Biochem Biophys Res Commun; 2012 May; 421(3):532-7. PubMed ID: 22521644
[TBL] [Abstract][Full Text] [Related]
30. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
31. Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells.
Singleton DW; Feng Y; Chen Y; Busch SJ; Lee AV; Puga A; Khan SA
Mol Cell Endocrinol; 2004 Jun; 221(1-2):47-55. PubMed ID: 15223131
[TBL] [Abstract][Full Text] [Related]
32. Expression of nuclear insulin receptor substrate 1 in breast cancer.
Sisci D; Morelli C; Garofalo C; Romeo F; Morabito L; Casaburi F; Middea E; Cascio S; Brunelli E; Andò S; Surmacz E
J Clin Pathol; 2007 Jun; 60(6):633-41. PubMed ID: 16882697
[TBL] [Abstract][Full Text] [Related]
33. Regucalcin is expressed in rat mammary gland and prostate and down-regulated by 17beta-estradiol.
Maia CJ; Santos CR; Schmitt F; Socorro S
Mol Cell Biochem; 2008 Apr; 311(1-2):81-6. PubMed ID: 18157649
[TBL] [Abstract][Full Text] [Related]
34. Identification of stage-specific breast markers using quantitative proteomics.
Shaheed SU; Rustogi N; Scally A; Wilson J; Thygesen H; Loizidou MA; Hadjisavvas A; Hanby A; Speirs V; Loadman P; Linforth R; Kyriacou K; Sutton CW
J Proteome Res; 2013 Dec; 12(12):5696-708. PubMed ID: 24106833
[TBL] [Abstract][Full Text] [Related]
35. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
36. 17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells.
Belkaid A; Duguay SR; Ouellette RJ; Surette ME
BMC Cancer; 2015 May; 15():440. PubMed ID: 26022099
[TBL] [Abstract][Full Text] [Related]
37. GREB 1 is a critical regulator of hormone dependent breast cancer growth.
Rae JM; Johnson MD; Scheys JO; Cordero KE; Larios JM; Lippman ME
Breast Cancer Res Treat; 2005 Jul; 92(2):141-9. PubMed ID: 15986123
[TBL] [Abstract][Full Text] [Related]
38. STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.
Ihlaseh-Catalano SM; Drigo SA; de Jesus CM; Domingues MA; Trindade Filho JC; de Camargo JL; Rogatto SR
Histopathology; 2013 Nov; 63(5):678-85. PubMed ID: 24025158
[TBL] [Abstract][Full Text] [Related]
39. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]